Skip to main content

9 Result(s)

within J Chilcott Remove this filter

and

  1. Article

    Open Access

    Guaiac faecal occult blood test performance at initial and repeat screens in the English Bowel Cancer Screening Programme

    In many countries, screening for colorectal cancer (CRC) relies on repeat testing using the guaiac faecal occult blood test (gFOBT). This study aimed to compare gFOBT performance measures between initial and r...

    B Kearns, S Whyte, J Chilcott, J Patnick in British Journal of Cancer (2014)

    Download PDF (282 KB) View Article

  2. No Access

    Article

    Modelling the Economics of Type 2 Diabetes Mellitus Prevention: A Literature Review of Methods

    Our objective was to review modelling methods for type 2 diabetes mellitus prevention cost-effectiveness studies. The review was conducted to inform the design of a policy analysis model capable of assisting r...

    P. Watson, L. Preston, H. Squires… in Applied Health Economics and Health Policy (2014)

  3. Article

    Open Access

    Reply: cost-effectiveness of population-based screening for colorectal cancer

    L Sharp, C Walsh, S Whyte, L Tilson, A O'Ceilleachair, C Usher… in British Journal of Cancer (2013)

    Download PDF (103 KB) View Article

  4. No Access

    Article

    Cost of care for colorectal cancer in Ireland: a health care payer perspective

    Management options for colorectal cancer have expanded in recent years. We estimated average lifetime cost of care for colorectal cancer in Ireland in 2008, from the health care payer perspective.

    L. Tilson, L. Sharp, C. Usher, C. Walsh… in The European Journal of Health Economics (2012)

  5. Article

    Open Access

    Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopy

    Several colorectal cancer-screening tests are available, but it is uncertain which provides the best balance of risks and benefits within a screening programme. We evaluated cost-effectiveness of a population-...

    L Sharp, L Tilson, S Whyte, A O'Ceilleachair, C Walsh, C Usher… in British Journal of Cancer (2012)

    Download PDF (703 KB) View Article

  6. No Access

    Article

    The costs and benefits of bowel cancer service developments using discrete event simulation

    Colorectal cancer includes cancerous growths in the colon, rectum and appendix and affects around 30 000 people in England each year. Maximizing health benefits for patients with colorectal cancer requires con...

    H Pilgrim, P Tappenden, J Chilcott… in Journal of the Operational Research Society (2009)

  7. No Access

    Article

    Assessment of a 7-day turn-around for the reporting of cervical smear results using discrete event simulation

    A discrete event simulation (DES) model has been used to analyse options with the potential to facilitate a 7-day turn-around of cervical screening results in England, with the aim of reducing the anxiety expe...

    H Pilgrim, J Chilcott in Journal of the Operational Research Society (2008)

  8. Article

    Open Access

    Cost-effectiveness of oxaliplatin and capecitabine in the adjuvant treatment of stage III colon cancer

    For many years, the standard treatment for stage III colon cancer has been surgical resection followed by 5-fluorouracil in combination with folinic acid (5-FU/LV). Ongoing clinical trial evidence suggests tha...

    S Eggington, P Tappenden, A Pandor, S Paisley, M Saunders… in British Journal of Cancer (2006)

    Download PDF (875 KB) View Article

  9. No Access

    Article

    Commentary on Coyle et al., "The assessment of the economic return from controlled clinical trials"

    Jon Karnon, A. Brennan, J. Chilcott in The European Journal of Health Economics,… (2003)